To include your compound in the COVID-19 Resource Center, submit it here.

First close for China Everbright’s new healthcare fund

China Everbright Ltd. (HKSE:165) completed the first close of

Read the full 99 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE